financetom
Business
financetom
/
Business
/
Lam Research Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Sets Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lam Research Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Sets Guidance
Oct 24, 2024 10:23 AM

04:54 PM EDT, 10/23/2024 (MT Newswires) -- Lam Research ( LRCX ) reported fiscal Q1 non-GAAP diluted earnings late Wednesday of $0.86 per share on a post-split basis, up from $0.67 a year earlier.

Analysts polled by Capital IQ expected $0.81.

Revenue for the quarter ended Sept. 29 was $4.17 billion, up from $3.48 billion a year ago.

Analysts surveyed by Capital IQ expected $4.06 billion.

For the December quarter, Lam expects non-GAAP earnings of $0.87 per share, plus minus $0.10, on revenue of $4.30 billion, plus minus $300 million.

Analysts surveyed by Capital IQ expect $0.85 on revenue of $4.25 billion.

Shares of the company rose about 5% in after-hours activity.

Price: 76.40, Change: +3.54, Percent Change: +4.86

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile
Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile
Nov 11, 2025
On Monday, Neurocrine Biosciences, Inc. ( NBIX ) said its Phase 2 study of NBI-1070770 in adults with major depressive disorder did not meet the primary endpoint compared to placebo, though it was generally well tolerated. Neurocrine Biosciences ( NBIX ) acquired the rights to develop and commercialize NBI-1070770 from Takeda Pharmaceutical Company, Ltd ( TAK ). The Phase 2...
Sector Update: Consumer
Sector Update: Consumer
Nov 11, 2025
01:15 PM EST, 11/11/2025 (MT Newswires) -- Consumer stocks were higher Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 1.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.2%. In corporate news, Paramount Skydance ( PSKY ) shares rose 10% after it reported a Q3 net loss late Monday of $0.01 per diluted share,...
What's Going On With Nvidia Stock Tuesday?
What's Going On With Nvidia Stock Tuesday?
Nov 11, 2025
Nvidia Corp ( NVDA ) shares are trading lower Tuesday afternoon following reports that SoftBank Group (OTC:SFTBF) offloaded its entire stake in the chipmaker. Here’s what investors need to know. What To Know: SoftBank sold 32.1 million shares of Nvidia ( NVDA ) in October, raising $5.83 billion to help fund its major investments in artificial intelligence, including a significant commitment...
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
Nov 11, 2025
Medical devices giant Medtronic Plc ( MDT ) is scheduled to report its second-quarter fiscal year 2026 results on Tuesday, November 18. According to data from Benzinga Pro, analysts estimate adjusted earnings of $1.315 per share and sales of $8.865 billion. Bank of America (BofA) Securities expects Medtronic ( MDT ) to post over 5% revenue growth in fiscal Q2, with momentum accelerating through...
Copyright 2023-2026 - www.financetom.com All Rights Reserved